2011 G (Orphenadrine Citrate Extended Release 100 mg)
Pill with imprint 2011 G is White, Round and has been identified as Orphenadrine Citrate Extended Release 100 mg. It is supplied by Amneal Pharmaceuticals LLC.
Orphenadrine is used in the treatment of muscle spasm and belongs to the drug class skeletal muscle relaxants. Risk cannot be ruled out during pregnancy. Orphenadrine 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 2011 G
Orphenadrine Citrate Extended Release
- Imprint
- 2011 G
- Strength
- 100 mg
- Color
- White
- Size
- 9.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Skeletal muscle relaxants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amneal Pharmaceuticals LLC
- Inactive Ingredients
-
ethylcelluloses, povidone, lactose monohydrate, magnesium stearate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00115-2011 | Global Pharmaceuticals |
| 42291-0530 | AvKare, Inc. |
| 68084-0820 | Amerisource Health Services |
| 66267-0158 | Nucare Pharmaceuticals Inc. (repackager) |
| 63874-0531 | Altura Pharmaceuticals Inc. (repackager) |
| 49999-0046 | Lake Erie Medical and Surgical Supply (repackager) |
| 55289-0877 | PDRX Pharmaceuticals Inc. (repackager) |
| 33261-0088 | Aidarex Pharmacuticals, LLC (repackager) |
Related Images for "2011 G"
More about orphenadrine
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 58 Reviews
- Drug class: skeletal muscle relaxants
Consumer resources
- Orphenadrine
- Orphenadrine (Advanced Reading)
- Orphenadrine Injection (Advanced Reading)
- Orphenadrine Extended-Release Tablets
- Orphenadrine Injection
Other brands: Norflex, Antiflex, Mio-Rel, Orfro, Orphenate
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
